Impedance Cardiography for Aortic Stenosis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method called impedance cardiography (ICG) to determine its effectiveness in detecting heart muscle issues in individuals with aortic stenosis, a condition where the heart's aortic valve narrows. Researchers aim to compare the results of this test with those from cardiac magnetic resonance (CMR), a specialized heart scan. They seek participants with aortic stenosis who have no history of heart attack or cardiac amyloidosis and have had or will have a CMR scan showing specific heart changes. Participants should have healthy skin at the test sites and be comfortable with the testing procedure. As an unphased trial, this study offers an opportunity to contribute to innovative research that could enhance heart health diagnostics.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that impedance cardiography is safe for detecting left ventricular decompensation in aortic stenosis patients?
Research shows that the test under study, called impedance cardiography (ICG), is usually easy for people to handle. One study found that ICG can assess heart function by measuring how electricity moves through the chest. Similar tests have reported no major side effects with ICG. Additionally, ICG has been used in other medical situations without significant safety issues. This suggests that the ICG test is likely safe for patients in this study.12345
Why are researchers excited about this trial?
Impedance cardiography for aortic stenosis is unique because it offers a non-invasive way to assess heart function by measuring electrical impedance changes. Unlike traditional methods like echocardiography or cardiac catheterization, which can be invasive and resource-intensive, impedance cardiography provides real-time data on how well the heart compensates for stress. Researchers are excited about this technique because it could lead to earlier detection of heart failure decompensation, potentially improving patient outcomes with quicker and more targeted interventions.
What evidence suggests that impedance cardiography is effective for detecting left ventricular decompensation in aortic stenosis?
Research has shown that impedance cardiography (ICG) can help detect heart problems related to aortic stenosis. One study used ICG on patients in different positions (sitting up and lying down) and found it promising for identifying when the heart struggles to pump blood effectively. Another study discovered that ICG could track changes in heart function without invasive procedures. This trial will use the ICG upright/supine test to further explore its potential in detecting heart issues in patients with aortic stenosis. Overall, these studies support the idea that ICG can provide important information about heart health in aortic stenosis.678910
Are You a Good Fit for This Trial?
This trial is for patients with aortic stenosis who have had recent cardiac magnetic resonance (CMR) scans without a history of heart attack or cardiac amyloidosis. It's designed to test if an impedance cardiography (ICG) test can detect heart issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Impedance Cardiography Test
Participants undergo the ICG upright/supine test using the HYPERGRAPH to assess compensatory response and detect decompensation
Cardiac Magnetic Resonance Imaging
Participants undergo a CMR scan to measure replacement fibrosis and correlate with ICG test results
Follow-up
Participants are monitored for safety and effectiveness after the ICG and CMR tests
What Are the Treatments Tested in This Trial?
Interventions
- Impedance Cardiography Upright/Supine Test
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dermed Diagnostics, Inc.
Lead Sponsor
Northwestern University
Collaborator